Loading...
XSHG
603938
Market cap2.37bUSD
Oct 09, Last price  
40.40CNY
1D
-2.39%
1Q
-23.47%
IPO
574.13%
Name

Tangshan Sunfar Silicon Industries Co Ltd

Chart & performance

D1W1MN
XSHG:603938 chart
P/E
192.51
P/S
7.37
EPS
0.21
Div yield, %
0.04%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
15.82%
Revenues
2.10b
+18.49%
485,302,557725,203,406823,582,935799,918,817791,748,6341,074,166,4441,103,852,4341,156,606,1161,006,252,0691,598,867,2452,648,321,0482,128,988,3271,769,763,4412,096,968,236
Net income
80m
+25.90%
23,058,65162,903,54891,257,07883,650,58881,074,306142,744,262113,050,175107,666,28597,358,416335,154,509747,826,155195,442,00663,778,92780,299,009
CFO
78m
-51.88%
82,551,10053,073,30031,228,3005,211,79053,679,5840108,085,66438,797,697180,054,395254,538,290473,164,747400,460,979162,677,59678,279,524
Dividend
Jun 09, 20260.022 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tangshan Sunfar Silicon Industries Co.,Ltd. is a Chinese enterprise specializing in the research, development, production, and commercialization of a diverse array of chemical products. The company's comprehensive portfolio includes various silicon derivatives such as trichlorosilane, silicon tetrachloride (available in high-purity and electronic grades), electronic grade dichlorodihydrosilane, and electronic grade trichlorosilane. Additionally, their offerings encompass fumed silica, silane coupling agents, potassium hydroxide, and sulfuric acid. Established in Tangshan, China, in 2006, the firm operates primarily within the domestic market.

Key people

Zhihong Chen
Finance Director · since 2017
Baifeng Wan
General Manager, Director · since 2017
Liqiang Dong
Deputy General Manager, Director · since 2017
Dawei Yao
Deputy General Manager, Secretary of the Board, Director · since 2017
Lianhui Zhou
Deputy General Manager · since 2017
IPO date
Jun 28, 2017
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
唐山市南堡开发区工业区(唐山氯碱有限公司北侧)
唐山市, HE 050000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT